The article reports:
Drug companies that have donated to Hillary Clinton’s foundation received most of the contract money from an international tuberculosis initiative after the foundation was brought on to manage the initiative’s procurement operation, public records show.
Two of every three dollars spent acquiring anti-tuberculosis drugs through the program, which is administered by the World Bank, have gone to two companies—Swiss health care giant Novartis and Indian drug company Lupin Ltd.—that together have donated up to $130,000 to the Clinton Foundation.
Clinton and her allies have pointed to the foundation’s international charitable work to deflect allegations of cronyism. However, the millions of dollars in contracts awarded to the two drug companies illustrate how foundation donors profited from laudable causes.
The article also points out:
Clinton has pointed to her foundation’s work in promoting access to pharmaceuticals in the developing world as an example of its laudatory humanitarian mission.
However, critics have noted how beneficiaries of other foundation-backed pharmaceutical access programs have made large financial contributions to the group. Companies that received funds from the foundation to provide low-cost HIV drugs, for instance, were donors to the foundation.
In many cases, the same companies were also lobbying the State Department for lucrative international health contracts while Clinton was secretary of state.
Despite years of collaboration with the industry, Clinton has described pharmaceutical companies as her “enemies,” even as lobbyists for the industry bankroll her presidential campaign.
Unfortunately, this kind of corruption has been going on with the Clintons for a very long time. It needs to end. If she is elected, the Clinton Administration will be a money-making scheme to enrich the Clintons while ignoring the problems and needs of America.